“People with Parkinson’s are very lucky to have L-dopa. There is no equivalent therapy for other neurodegenerative conditions like Alzheimer’s, Huntington’s, or Lou Gehrig’s disease. Whatever its limitations, L-dopa turned Parkinson’s from a condition in which victims experienced a rapid slide toward immobility and death into a chronic disease with a gradual trajectory of decline. A.”

“People with Parkinson’s are very lucky to have L-dopa. There is no equivalent therapy for other neurodegenerative conditions like Alzheimer’s, Huntington’s, or Lou Gehrig’s disease. Whatever its limitations, L-dopa turned Parkinson’s from a condition in which victims experienced a rapid slide toward immobility and death into a chronic disease with a gradual trajectory of decline. A.”

— Jon Palfreman